A Phase 3, Randomized, Double Blind, Placebo And Active‑Controlled, Multicenter, Parallel‑Group Study Of The Analgesic Efficacy And Safety Of Tanezumab In Adult Subjects With Chronic Low Back Pain
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 01 Dec 2017
At a glance
- Drugs Tanezumab (Primary) ; Tramadol
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Acronyms TANGO
- Sponsors Pfizer
- 27 Nov 2017 Status changed from suspended to active, no longer recruiting.
- 20 Nov 2017 Status changed from active, no longer recruiting to suspended.
- 30 Oct 2017 Status changed from recruiting to active, no longer recruiting.